CALIVIDA contains levocetirizine dihydrochloride, a new-generation anti-histamine, is available in the following dosage forms:
  • 0.5mg/ml strawberry flavored oral solution in a 200ml bottle
  • 5mg film-coated tablets, packs of 28

CALIVIDA is indicated for the treatment of seasonal, perennial and persisting allergic rhinitis (hay fever and pollinosis), allergic conjunctivitis and chronic idiopathic urticaria.